🔎 Trials Near Me

Home › Mesothelioma › New York › New York City

Mesothelioma clinical trials in New York City, NY

10 studies for Mesothelioma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

RecruitingPhase 1
  • Columbia University Irving Medical Center, New York
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

RecruitingObservational study
  • NYU Langone Medical Center, New York
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Recruiting
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ages 30 to 85 · All sexes · Updated Sep 24, 2026 · NCT06037941

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

RecruitingPhase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06057935

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

RecruitingPhase 1/2
  • New York University Langone Health, New York
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

RecruitingPhase 1
  • David H Koch, Memorial Sloan Kettering Cancer Center, New York
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

RecruitingPhase 1/2
  • NYU Langone Medical Center, New York
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695

A Study of Sacituzumab Govitecan in People With Mesothelioma

RecruitingPhase 2
  • Memorial Sloan - Kettering Cancer Center, New York
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT06477419

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

RecruitingPhase 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT04665206

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

RecruitingPhase 1/2
  • Weill Cornell Medicine, Cornell University (site 126), New York
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228

About Mesothelioma

Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.

More about Mesothelioma on MedlinePlus

Mesothelioma trials in other cities

Other studies in New York City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.